NAFTIN 2% GEL Rx
Generic Name and Formulations:
Naftifine HCl 2%.
Indications for NAFTIN 2% GEL:
Interdigital tinea pedis.
Adults and Children:
T. pedis/cruris: <12yrs: not established. ≥12yrs: Apply thin layer once daily to affected areas plus a ½ inch margin of healthy surrounding skin for 2 weeks. T. corporis: <2yrs: not established. ≥2yrs: Apply thin layer once daily to affected areas plus a ½ inch margin of healthy surrounding skin for 2 weeks.
Not for ophthalmic, oral or intravaginal use. Discontinue if irritation or sensitivity develops. Pregnancy. Nursing mothers.
Application site reactions, pruritus.
Crm, Gel—45g, 60g
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally